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Abstract: This paper is a summary of presentations on postoperative pain control by the 
authors at the 2014 PainForum meeting in People’s Republic of China. Postoperative pain is 
often untreated or undertreated and may lead to subsequent chronic pain syndromes. As more 
procedures migrate to the outpatient setting, postoperative pain control will become increas-
ingly more challenging. Evidence-based guidelines for postoperative pain control recommend 
pain assessment using validated tools on a consistent basis. In this regard, consistency may be 
more important than the specific tool selected. Many hospitals have introduced a multidisci-
plinary acute pain service (APS), which has been associated with improved patient satisfaction 
and fewer adverse events. Patient education is an important component of postoperative pain 
control, which may be most effective when clinicians chose a multimodal approach, such as 
paracetamol (acetaminophen) and opioids. Opioids are a mainstay of postoperative pain con-
trol but require careful monitoring and management of side effects, such as nausea, vomiting, 
dizziness, and somnolence. Opioids may be administered using patient-controlled analgesia 
systems. Protocols for postoperative pain control can be very helpful to establish benchmarks 
for pain management and assure that clinicians adhere to evidence-based standards. The future 
of postoperative pain control around the world will likely involve more and better established 
APSs and greater communication between patients and clinicians about postoperative pain. The 
changes necessary to implement and move forward with APSs is not a single step but rather 
one of continuous improvement and ongoing change.
Keywords: pain control, postoperative pain, acute pain, pain assessment, analgesia
Introduction
This paper presents results from the 2014 PainForum meeting in People’s Republic 
of China. The goal of the meeting was to describe the current state of postoperative 
pain management, identify challenges, and propose solutions for the future to allow 
for better and safe treatment of postoperative pain.
Even with our current knowledge and an armamentarium of analgesic agents, 
postoperative pain management has not changed much in the past two decades and 
much postoperative pain is not optimally treated. In a survey in the US dating back 
to 1995, 57% of patients reported postsurgical pain as a concern prior to surgery and 
80% reported moderate-to-severe pain after surgery.1 In a 2003 survey of 250 patients 
undergoing surgery, 33% were concerned about pain during surgery and 59% (the larg-
est group) were concerned about pain following surgery.2 That fear is not unfounded: 
in that same survey, 82% of patients reported some degree of postsurgical pain, with 
47% rating that pain moderate, 21% severe, and 18% extreme.2 A total of 30%–40% 
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of day surgery patients experience moderate-to-severe post-
operative pain.3,4 Postoperative pain can delay discharge, may 
cause an unexpected hospital admission,5 and it can create 
pain, stress, and anxiety for patients and their family, possibly 
interfering with rehabilitation.4,6 Unplanned contacts between 
patient and physician following surgery are often the result 
of undermanaged pain; in Finland, 31% of surgical patients 
made unplanned contact with clinical staff because of pain.7 
In fact, pain is the main reason for unanticipated hospital 
admissions of day surgery patients (36%).6
There are particularly important reasons for undertreated 
pain following ambulatory surgery, which is increasingly 
common. Outpatient procedures are more and more complex, 
and they are offered in the setting of many innovative new 
analgesic agents, techniques, and surgical tools. Ambulatory 
patients may have lower adherence than hospital inpatients 
who are under closer clinical supervision. In fact, left on their 
own, patients do not always use medications as prescribed,8 
a phenomenon that has not changed much since 1979 when 
Sackett found typical adherence rates in patients with hyper-
tension to be ∼50%.9
A variety of adverse outcomes have been associated with 
undertreated perioperative pain, including the possibility that 
chronic pain could result.
The risks of chronic postsurgical 
pain
The development of chronic pain syndromes following 
surgery is not rare and may be unappreciated by clinicians. 
The incidence of chronic postsurgical pain varies by surgery, 
but may be as high as 85% (amputations); patients who have 
undergone mastectomy face a 20%–50% incidence of chronic 
pain, who have undergone herniorrhaphy 5%–35%, who 
have undergone thoracotomy 30%–40%, who have under-
gone breast surgery 20%–30%, and who have undergone 
coronary artery bypass graft surgery 30%–50%.10 The risk 
factors for developing chronic pain after surgery are several: 
preoperative pain, repeat surgery, prolonged surgery, younger 
age, severe postoperative pain, surgical approaches with a 
higher risk of nerve damage, chemotherapy or radiation, 
and some psychological or depressive symptoms.10 Some 
of these risk factors are beyond the control of the clinician, 
such as the degree of preoperative pain or the patient’s age. 
The main risk factor under clinical control is the degree of 
postoperative pain the patient endures.
Numerous guidelines address the important subject of 
postoperative pain control.11–14 The American Society of 
Anesthesiology guidelines, updated in 2012, were created to 
facilitate safe and effective pain management in the periop-
erative setting, reduce adverse outcomes, maintain patient’s 
function and well-being, and enhance the patient’s quality 
of life in the perioperative period.15 A crucial first step in 
postoperative pain control according to the guidelines is 
regular, consistent pain assessment.
Pain assessment and communication
Pain assessment is recognized by virtually all of the 
pain guidelines as a crucial step in providing good pain 
management. The foundation of the pain assessment is the 
patient’s self-report of pain, but most patients lack the ability 
to discuss pain in a clinically meaningful way. For that rea-
son, a variety of tools have been introduced to help patients 
and clinicians “speak the same language” about the pain. 
Although clinicians may feel it is most natural to ask patients 
open-ended questions about their pain (“how are you feel-
ing today?”), this is the least effective means of measuring 
pain because patients and clinicians are not calibrated to 
use terms the same way. Further, some patients avoid talk-
ing about pain because they think it might be a form of 
complaining, perceived as a sign of weakness, viewed by 
the doctors and nurses as bothersome, or that postsurgical 
pain is unavoidable. Pain assessments must be carried out 
frequently, ideally according to a schedule, because pain is 
dynamic and changes with the patient’s condition, therapies, 
underlying disease, and other factors.
verbal descriptor scale
The verbal descriptor scale (VDS) involves setting up 
five specific terms to describe pain; at the extremes are 
“no pain” and “worst pain possible”. In addition to those 
two poles, the patient may select “mild”, “moderate”, or 
“severe” pain. Patients should be instructed to use only one 
of these five terms, and it is not uncommon in practice for 
patients to try to seek middle ground (“mild to moderate” 
or “moderate to severe”). The VDS is easy to use, intui-
tively understandable, and provides valuable pain assess-
ment feedback. A potential drawback of this scale occurs 
when patients have difficulty communicating, for instance, 
because of language barriers or cognitive disorders. Note 
that for reliability in a clinical setting, clinicians must use 
the same terms each time.
visual analog scale
The visual analog scale (VAS) involves a straight line of 
10 cm with tick marks, starting with 0 and indicating each 
centimeter; smaller lines may indicate millimeters. The patient 
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is instructed that 0 indicates no pain and 10 cm indicates the 
worst pain possible. The patient is then asked to indicate on 
the line “how much” pain he or she is experiencing. As a 
general rule, pain $3 cm demands treatment; pain $6 cm 
should be considered severe.
Numerical rating scale
The numerical rating scale works on a similar principle as the 
VAS, but instead of pinpointing the pain level on a straight 
line, the patient merely selects the number from 0 to 10 to 
describe his or her pain.
Other pain assessment tools
All of these pain assessment tools are easy to deploy 
and interpret. Other pain scales exist as well, such as the 
Red Wedge Scale and the Box Scale (a scale made up of 
21 numbers in boxes). Some tools rely on photographs of 
faces or smiley/frowning cartoons to help patients describe 
their pain.16 These assessment tools may be particularly 
advantageous with pediatric patients or patients who do not 
speak the local language. A clinical practice should use only 
one assessment tool and use it consistently so that pain assess-
ment results can be meaningfully compared and evaluated. In 
a study of 140 surgical patients with hip fracture or lower limb 
trauma, for elderly patients, the VDS and Red Wedge were 
the most applicable assessment tools, while the VAS was 
least reliable although still provided acceptable results.17
The use of one particular pain assessment tool over others 
is largely a matter of clinical or clinician preference. Optimal 
results require consistent use of one particular pain assess-
ment tool in a clinical setting; however, it is less important 
which particular tool is used than that one tool be selected 
and used consistently.
Despite the wealth of pain assessment tools available, cli-
nicians must often treat patients who are completely unable to 
communicate. In this instance, behavioral observations can be 
helpful. Distorted postures, grimacing, grunting, reluctance to 
move, muscle tension, agitation, difficulty breathing deeply, 
and problems sleeping may all indicate pain.18 When treating 
critically ill or uncommunicative patients, clinicians should 
consider assessing and comparing pain both during rest and 
with movement; however, behaviors that can suggest pain 
may also be indicators of potential surgical complications.
For practical reasons, postsurgical pain assessment car-
ried out in the hospital must be brief and straightforward. 
When pain is identified, it should be promptly treated. 
This may require revamping institutional and procedural 
policies. Patients and clinical staff should be trained as to 
why prompt analgesic intervention is so important. Finally, 
hospitals and surgery centers should consider making it a 
criterion for discharge that the patient’s pain is adequately 
controlled.
The role of the acute pain service
In the UK, hospitals have introduced a multidisciplinary 
acute pain service (APS) to manage postoperative pain, 
develop appropriate guidelines and training materials, con-
duct research into acute pain, and audit hospitals.19 The APS 
paradigm, which has been introduced in other parts of the 
world as well, holds promise in improving postoperative pain 
care and may help identify some of the risk factors for chronic 
postsurgical pain. Among these risks are patient factors (pre-
operative pain, repeat surgery, psychological vulnerability, 
preoperative anxiety, female sex, younger age, being on 
worker’s compensation, etc), intraoperative factors (surgical 
approach with likelihood of nerve damage), and postoperative 
factors (radiation, chemotherapy, depression, psychological 
vulnerability, and moderate-to-severe acute pain).20
The benefits of APS include decreases in pain intensity 
levels among patients, improved patient satisfaction, and 
fewer adverse events associated with pain therapy.21 APS 
can better identify patients at risk for developing chronic 
postoperative pain and thus treating physicians can deploy 
more targeted interventions. Further, APS team members can 
provide education, training, and assurance that guidelines and 
evidence-based pain control are implemented.
The importance of patient education
Patients, even highly educated patients, may not know what 
to expect following surgery. To that end, it is helpful if the 
clinical team discusses pain expectations with the patient in 
advance, specifically, whether the patient should anticipate 
pain following surgery, how long the pain might be expected 
to last, how intense the pain might be, and what kind of pain 
treatments are available. A crucial step in surgical patient 
education is a frank discussion of the risks of untreated 
postsurgical pain with respect to development of chronic 
pain and delays in rehabilitation and recovery. Patients should 
also be informed about analgesic agents and their risks and 
benefits and encouraged to ask questions. It is not unusual 
to find that many patients underestimate or overestimate the 
potential risks of opioid analgesics.
Not all pain therapy has to be pharmacological. Where 
appropriate, patients should be told about nonpharmacologi-
cal pain control options that can be very helpful, such as cold 
or heat therapy, massage, physical therapy, and they may also 
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be urged to develop their own strategies to distract themselves 
from pain, for example, by listening to music or watching 
TV. When special techniques, such as an epidural injection 
or wound infiltrations, are used or new equipment such as 
patient-controlled analgesia (PCA) is introduced, patients 
should be instructed about their purpose and how they work. 
Patients are likely to be more compliant and better satisfied 
with their care when they understand their treatment. In a 
study of 322 surgical patients, a simple illustrated booklet 
about pain distributed to patients prior to surgery improved 
patient knowledge about the procedure and served to better 
standardize communication between patients and clinicians 
about pain and anesthesia.22
Multimodal postoperative analgesia
Postoperative pain is the likely outcome after surgery; for that 
reason, proactive approaches to pain control are appropriate 
for all surgical patients. This may include so-called preemp-
tive analgesia, the preoperative administration of analgesic 
so that it is active during surgery and can reduce nociceptive 
transmissions (which may, in turn, decrease postoperative 
pain), and preventive analgesia to help block central sensi-
tization by blocking neural transmission of noxious stimuli. 
Preoperatively, this might mean such treatments as non-
steroidal anti-inflammatory drugs (NSAIDs; eg, ketorolac), 
anxiolytics (eg, midazolam), and anticonvulsants (such as 
gabapentin), but data remain equivocal.23 Since postsurgi-
cal pain tends to be multimechanistic (for instance, having 
a nociceptive as well as neuropathic component), effective 
pain control involves multimodal therapy.
The term “multimodal analgesia” was coined by Kehlet 
to describe the combined use of different analgesics and/
or analgesic techniques to improve pain control.24 When 
analgesic agents with complementary mechanisms of action 
are utilized, there may be an additive benefit (the benefit 
is the result of the sum of the parts) or even a synergistic 
benefit (the benefit is greater than the sum of the parts).25 
Furthermore, multimodal analgesia may reduce the adverse 
effects that would have occurred with monotherapy. Early 
and aggressive pain control may be able to slow the acute 
neuroplastic responses following surgery (leading to central 
sensitization).26,27
Multimodal analgesic combinations may involve nono-
pioid agents, opioids, or both. NSAIDs and acetaminophen 
have been shown to be effective as monotherapy against post-
surgical pain28–30 and may be more effective in combination 
(NSAID/acetaminophen).31 Intravenous (IV) acetaminophen 
for postoperative pain control appears to be not only effective 
but also well tolerated.29 NSAIDs are effective against post-
operative pain, but their effects may contraindicate their 
widespread use. For example, NSAIDs may interfere with 
platelet function,32,33 may be contraindicated in patients with 
compromised renal function,34 may cause or exacerbate 
gastrointestinal disorders,35,36 may promote bronchospasm 
in asthmatics sensitive to aspirin and/or certain NSAIDs,37 
may interfere with bone healing,38 and may carry with them 
cardiovascular risks.39–41 NSAIDs may also interfere with 
the platelet effect of low-dose aspirin.42 However, nonopioid 
analgesics are appropriate and effective for control of mild 
to moderate pain.
For severe acute pain, the most commonly used medi-
cation in Finland remains oxycodone, which has become a 
cornerstone of postoperative pain control there.43,44 Oxy-
codone is available in IV, intramuscular, subcutaneous, 
intranasal, and per oral (PO) formulations. Oxycodone is 
well absorbed after PO dosing, with a bioavailability of 
around 60%–87%.45,46 Oxycodone intranasal has a mean 
bioavailability of 46%.47 Oxycodone doses and routes of 
administration reported from Finnish hospitals are sum-
marized in Table 1.43
The safe and effective use of any opioid agent involves 
titrating the drug until the patient achieves analgesia as 
determined by the patient’s own self-report. Patients who 
ask for more opioid usually have inadequate analgesia or are 
going too long between doses (so-called “analgesic gaps” are 
occurring) or the clinical team may not be paying adequate 
attention to the patient and his needs.48
Considerations on the use of opioids 
for postoperative pain control
Mu-opioid receptor agonists are associated with certain 
well-known adverse events, which can in some instances 
limit treatment. Some can be antagonized with the non-
selective opioid receptor agonist naloxone. Among these 
opioid-associated side effects are respiratory depression 
(potentially life threatening), difficulty breathing, nausea, 
vomiting, postoperative nausea and vomiting, sedation, 
somnolence, constipation, urinary retention, and itching.49 
Many opioid-associated side effects can be managed, for 
example, nausea and vomiting with antiemetics. The use of 
opioid analgesics in the postoperative setting is generally 
brief, and the short duration of opioid exposure may limit 
the frequency and/or severity of typical opioid-associated 
side effects.
PCA allows the patient to control a device that admin-
isters a programmed amount of IV opioid. Devices can be 
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Table 1 Oxycodone routes of administration and doses used in Finnish hospitals
Patient  
ages (years)
IV bolus  
(dosing interval  
10–15 minutes)
IV PCA (oxycodone 2 mg/mL, 
droperidol 0.05 mg/mL;  
lockout 6–10 minutes)
TM (dosing interval 
15–30 minutes)
IR tablet PO or liquid  
PO (dosing interval  
30–60 minutes)
CR tablet 
(BID)
12–17 0.05–0.1 mg/kg 0.02 mg/kg 5–10 mg 5–10 mg 10–20 mg
18–65 3 mg 1–2 mg 10 mg 5–10 mg 20 mg
.65 to ,80 2 mg 1 mg 5 mg 5 mg 5–10 mg
.80 1 mg 1 mg 5 mg 5 mg 5 mg
Note: copyright © 2012. taylor & Francis Ltd. Kokki H, Kokki M, sjovall s. Oxycodone for the treatment of postoperative pain. Expert Opinion on Pharmacotherapy. 
2012;13(7):1045–1058. Reprinted by permission of the publisher (taylor & Francis Ltd, http://www.tandfonline.com).43
Abbreviations: BiD, twice a day; cR, controlled release; iR, immediate release; iv, intravenous; PcA, patient-controlled analgesia; PO, per oral (by mouth); tM, transmucosal.
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programmed to specific concentrations, bolus doses, back-
ground infusions, and lockout times to prevent overdose. 
When a patient is given PCA equipment for postoperative 
pain control, it is important to educate the patient both 
in terms of device operation and medication risks. PCA 
patients should be regularly monitored, their pain regularly 
assessed, and drug consumption noted. PCA oxycodone (or 
other opioid) should be discontinued when the patient is not 
taking boluses regularly and is able to take PO medication; 
PCA oxycodone can be readily converted to oxycodone 
PO doses.
Epidural analgesics may be necessary for certain types 
of high-risk patients and can offer superior pain control 
compared with other techniques when a local anesthetic 
is combined with an opioid.50 In a study of 18 mastectomy 
patients with patient-controlled epidural analgesia had 
significantly lower pain scores and significantly shorter 
hospital stays (25 hours) than similar patients who had 
PCA.51 Other comparative studies have had equivocal 
results.52
Another technique for postoperative analgesia involves 
the localized infiltration of the deep tissue layers with a large 
volume of anesthetic solution and additive; the patient also 
has access to PCA opioids. The goal behind local infiltration 
is the theory that early, aggressive pain relief localized to the 
injury can prevent central sensitization. Local infiltration 
does not expose patients to the risk of epidural hematoma 
or motor block, and there is no risk of urinary retention. In 
a study of local infiltration analgesia for patients with knee 
and hip surgery, 325 patients were treated with the protocol 
of systematic infiltration of the tissue with ropivacaine, 
ketorolac, and adrenaline. Most patients did not require res-
cue morphine analgesia and most could walk with assistance 
within 5–6 hours following surgery; 71% were discharged 
after one night in the hospital.53
The types of infiltration solution vary. The literature 
has described levobupivacaine + adrenaline + ketorolac;54 
other infiltrates might include NSAIDs, acetaminophen, and 
anticonvulsants. The patient should have access to rescue 
medication, as needed, such as PCA IV oxycodone or oxy-
codone PO (5–10 mg).
Regional anesthesia requires the clinician to put the 
right dose of the right drug in the right place. While there 
is not a body of evidence in the literature in support of 
ultrasound-guided regional blocks, it seems intuitively 
understandable that the correct use of ultrasound imaging 
would increase regional anesthesia safety.55 Regional anes-
thesia may be supplemented with certain adjuvant agents, 
such as adrenaline (to promote vasoconstriction) and 
clonidine (to help prolong analgesia by affecting A-α and 
C-fibers).56,57
Best practices for postoperative 
pain control
While some public health officials have argued that pain 
control is a fundamental human right,58,59 there are practi-
cal, clinical reasons for effectively controlling postopera-
tive pain.60 First, there is growing evidence – along with the 
intuitive sense of most clinicians – that effective analgesia 
facilitates ambulation and rehabilitation.
The Royal College of Anesthetists has set forth best 
practice standards for postoperative pain control.61 For 
all patients for all surgeries, pain should be ,4 on an 
11-point VAS within 30 minutes in the recovery room. 
Patients should also be pain free at rest. Before patients are 
discharged, they should be given regular and breakthrough 
analgesic agents along with dosing instructions and, if 
necessary, antiemetic therapy. This is more complicated 
for patients at risk for cardiorespiratory morbidity; they 
may require more dynamic analgesia to adjust to their 
condition. If analgesia fails, this failure should be detected 
within no .2 hours and managed appropriately to restore 
analgesic relief.
While these principles seem reasonable and laudable, the 
challenge for busy real-world clinics is finding practical and 
efficient ways to implement best practices. That can be done 
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by establishing pain protocols, using multimodal analgesic 
regimens, and setting up APS.
Establishing protocols for 
postoperative pain
A written protocol for best practices for postoperative pain 
should be developed. This should encompass certain established 
benchmarks: patients should be educated about the risk, benefits, 
and dosing instructions of their medicines and prescribed break-
through pain medication (where appropriate) and antiemetic 
agents, if required. Patients should have a pain score on an 
11-point scale of ,4 within 30 minutes in the recovery room 
after surgery, with the goal that in recovery room, the patient can 
be pain free while at rest. This means pain should be assessed 
regularly using an established tool, which, in turn, means that 
the entire clinical team must be trained in the use of such tools. 
Postoperative analgesia should generally involve multimodal 
analgesia and may include IV or epidural PCA systems. The pro-
tocol should also allow for adjustments to the regimen in patients 
who are at risk for cardiorespiratory morbidity. Shortfalls, gaps, 
or failures of the analgesic protocol should be promptly detected 
and rectified, in no .2 hours. Further, the protocol set forth by 
a hospital should be subject to periodic audit.
A number of guidelines relating to postoperative pain 
control have been written in the past decades. A search in 
PubMed for “postoperative pain guidelines 2014” yielded 
94 results from that year alone. The American Society of 
Anesthesiologists (ASA) revised its 2004 comprehensive 
guidelines in 2012 (Table 2).15
The ASA guidelines are succinct, comprehensive, and 
scientifically sound; they are based on the fundamental rec-
ognition that pain relief is important and that current practice 
must be continually reviewed and updated.15 This leads to 
the question as to whether international postoperative pain 
relief guidelines could be formulated, based on the ASA 
guidelines and other international publications, such as work 
by Wu and Raja.62 Some drawbacks exist to the creation of 
global protocols. First, clinician education and institutional 
capacity vary, sometimes markedly, in different parts of the 
world. Second, the resources of health care systems vary by 
geography. Finally, patient populations as well as patient 
attitudes and expectations can vary in different parts of the 
world. For example, some cultures harbor profound aver-
sions to opioids in any context; other cultures may accept 
pain stoically and consider it a sign of weakness to take pain 
relievers. None of these need to become obstacles, but they 
Table 2 A brief summary of AsA guidelines for acute perioperative pain management
Area Recommendations
institutional policies and procedures training and education of health care providers
Monitoring patient outcomes and documentation
Monitoring patient outcomes at institutional level
Round-the-clock availability of anesthesiologists for perioperative pain management based on 
standardized institutional policies and procedures
Use of APs
Preoperative evaluation of the patient Preoperative assessment and individualized plan (based on type of surgery, anticipated pain levels, 
underlying conditions, risk/benefit of various analgesics, and patient preferences)
Physical examination and patient history
Preoperative preparation of the patient Adjustments or continuations of any medications that should not be discontinued because of 
possible withdrawal symptoms
treatments to reduce preexisting pain
treatment to relieve anxiety
Premedications as part of a multimodal pain management program
Patient and family/caregiver education, including behavioral pain control techniques
Perioperative pain management May include, but is not limited to, central regional opioid analgesia, PcA with systemic opioid 
agents, and peripheral regional analgesia
the abovementioned modalities should be given preference over intramuscular opioids “as needed”
Selections must reflect the expertise of the anesthesiology team and the capacity for safe application 
at the practice setting
exercise caution with continuous infusion modalities
Multimodal pain management Whenever possible, multimodal analgesic techniques should be used, such as central regional 
blockade with local anesthetics
Unless contraindicated, patients should receive round-the-clock NsAiDs, coxibs, or acetaminophen
All dosing should optimize efficacy while minimizing the risk of adverse events
the choice of medication must be individualized (agent, dose, route, and duration of therapy)
Note: there are varying levels of evidence for these steps.
Abbreviations: ASA, American Society of Anesthesiologists; APS, acute pain service; NSAIDs, nonsteroidal anti-inflammatory drugs; PCA, patient-controlled analgesia.
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do merit consideration in formulation of global protocols. 
To set up any sort of basic preoperative pain relief protocol, 
established practices around the world should be reviewed 
and participation by local surgeons, anesthesiologists, and 
pain specialists is necessary. Furthermore, it must also be 
considered if there are any national differences in terms of 
who is in charge of postoperative pain control and how it is 
regulated.
The PAIN-OUT research project was set up to develop 
evidence-based approaches to improve postsurgical pain con-
trol by working with 14 collaborating hospitals in 13 nations. 
It achieved its proof-of-concept by ascertaining that it could 
obtain reasonably complete and good-quality data (only 2% 
of process and 0.06% of patient-reported outcome data were 
missing).63
The role of evidence in establishing sound postoperative 
pain protocols cannot be overstated. For example, epidural 
analgesia for postoperative pain was once considered a “gold 
standard” but that standard could not be supported by new 
evidence.64 It had previously been thought (based on “old 
evidence”) that postoperative epidural analgesia decreased 
30-day postoperative mortality, pneumonia, and deep vein 
thrombosis and shortened intensive care unit and hospital 
length of stay. However, scrutiny of this evidence has deter-
mined that some of those studies were flawed, that epidural 
analgesia did not have better mortality than systemic opioids, 
and that changes in surgical techniques and rehabilitation 
have impacted lengths of stay.64 The failure rate of epidural 
analgesia must also be considered, which has been stated as 
32%–50%.65,66 Thus, epidural analgesia should be evaluated 
for postoperative analgesia only in highly selected cases and 
for patients who are otherwise at high risk for other analgesic 
regimens.
Surgical techniques, surgical tools, surgical procedures, 
and surgical facilities have all undergone profound changes 
in the past years. Many procedures which once required 
open surgical techniques can be performed laparoscopically, 
the number of procedures and patients who are appropriate 
candidates for outpatient procedures continues to expand, 
and advanced surgical tools and innovations have further 
facilitated once-complex procedures. These changes have 
had and continue to make a profound impact on postsurgi-
cal pain.
Specific postoperative pain management protocols have 
demonstrated effectiveness (Table 3) and may reduce pain, 
improve patient satisfaction, shorten hospital stay, reduce 
infections, improve sleep quality, lower readmission rates, 
and reduce side effects. Many studies have evaluated 
hospital data prior to the implementation of a protocol 
and then after the protocol was applied, often demonstrat-
ing a marked improvement in specific variables with the 
protocols.
Optimizing postoperative pain 
control
Multimodal analgesia may help optimize postoperative 
analgesia. In a meta-analysis of 52 randomized clinical tri-
als (n=4,893 adults), multimodal analgesia in postoperative 
patients was associated with 15%–55% less opioid consump-
tion, 10%–15% lower postoperative VAS pain scores, and 
15%–25% fewer opioid-associated adverse events.72 However, 
certain adverse events went up, such as severe bleeding (from 
0% to 1.7% and renal insufficiency from 0% to 1.4% but this 
increase was seen only in cardiac patients).
Oxycodone works well in a multimodal analgesic plan. It 
is versatile, available as an PO, IV, or combination product, 
and can be used in PCA systems. Oxycodone has been used 
safely and effectively for postoperative pain control fol-
lowing diverse types of surgery, including, but not limited 
to, facial surgery,73 breast surgery,74 back surgery,74 ENT 
procedures,75 abdominal surgery,76 ocular procedures,77 
neurosurgery,78 and urological procedures.79
Opioids are a broad class of drugs currently available in 
many different agents, doses, formulations, and routes of 
administration. Broadly, opioids may be grouped as mu-opioid 
receptor agonists, such as morphine; partial agonists, such as 
buprenorphine; and agonist-antagonists, such as butorphanol 
and pentazocine. While various opioid agents present unique 
pharmacokinetics and pharmacodynamics, there are some 
broad considerations about some of the best-known agents. 
Morphine, long considered the “gold standard” of opioid 
analgesia, has a slow onset of action and can be associated 
with toxicity and tolerability issues. Pethidine has a high 
toxicity. Fentanyl is a strong opioid, but it has a short duration 
of action and must be closely monitored to avoid the risk of 
accumulation in the body. Sufentanil is lipophilic. We should 
consider oxycodone in a special light here, because its use in 
postsurgical pain control is increasing globally.44
Oxycodone is a versatile opioid analgesic, in that it has 
demonstrated safety and effectiveness in experimental noci-
ceptive pain,80,81 postoperative pain,82,83 visceral pain,84–86 bone 
pain (fractures),87 cancer pain,88,89 hyperalgesic syndromes,80 
and neuropathic pain.90
In a study of ten healthy volunteers, tolerance to PO oxy-
codone (0 mg, 5 mg, and 20 mg) was compared over 5 days. 
No difference in analgesic effect occurred from day 1 to 
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day 5, although tolerance did develop to some of the positive 
subjective effects of oxycodone in a subset of patients.91
Potential pharmacokinetic drug–drug interactions 
should be considered with oxycodone. Oyxcodone is 
metabolized via the cytochrome P2D6 and 3A4 substrates. 
Potential interactions may occur when the patient concur-
rently takes known 2D6 or 3A4 inhibitors or inducers.44,92,93 
Genetic polymorphisms are known to affect other opioid 
agents, but only cytochrome P polymorphism affects 
oxycodone.94
In a double-blind study of 39 abdominal surgery patients, 
pain could be controlled over 2 hours with less oxycodone 
than morphine, and oxycodone was associated with fewer 
adverse events.76 In a study comparing oxycodone to fen-
tanyl (median doses 15 mg and 200 µg, respectively) in 
78 laparoscopic cholecystectomy patients, pain intensity 
overall was significantly lower in the oxycodone group at 
30 minutes, 60 minutes, and 90 minutes and at discharge from 
the postanesthesia care unit, with these differences achiev-
ing significance at 30 minutes and 60 minutes; both oxy-
codone IV and fentanyl IV had similar rapid onset of action 
(∼2 minutes or 3 minutes after injection).95 In a comparative 
study of oxycodone vs morphine over the first 24 hours after 
surgery, there was significantly more accumulated morphine 
detected than oxycodone (22.0±13.1 mg vs 13.3±10.4 mg, 
respectively, P=0.006).96
Oxycodone may be easily switched from an IV route of 
administration to an PO product.97
Clinical realities: past, present,  
and future
The United States98 and Germany99 were the first nations to 
introduce the APS to perioperative care in 1985. By 1993, 
34% of European hospitals surveyed in 17 countries had a 
formal APS program.19 By 1995, 42% of the US hospitals 
had established an official APS.1,100 The APS model has 
introduced specialized pain control and new techniques (such 
as PCA and epidural analgesia) and has certain key overarch-
ing responsibilities: identifying training opportunities for the 
clinical team involved in postoperative pain, auditing existing 
procedures, and researching new and innovative methods of 
pain control.21 The structure of an APS may vary by institu-
tion to institution. Some are multidisciplinary organizations, 
others are led and run by nurses, and some are led and run 
by physicians, possibly in consultation with a pharmacist or 
physiotherapist.21
In a retrospective analysis based on 44 audits and four 
clinical trials (n=84,097 postoperative patients), an APS 
program significantly decreased pain scores21 and may 
reduce hospital length of stay for some surgeries.101 Data 
related to their cost-effectiveness are more limited, although 
one study reported a net savings of approximately US$45 per 
patient with an APS, based on the cost of the program offset 
by shorter stays.102 In a large prospective study (n=5,837), 
there were significantly fewer postoperative patients report-
ing “worst pain” in hospitals with an APS than in hospitals 
without (P,0.00001).103 Postoperative patients in a hospital 
with APS reported significantly “less pain than expected 
after surgery” (P,0.01).103 The incidence of lower respira-
tory tract infection decreased from 1.3% to 0.4% in a retro-
spective study once an APS was started (P,0.01).104
The implementation of advanced analgesic techniques 
and a formal APS may lead to an increase in drug-related 
morbidity and adverse effects, although the relationship of 
APS and adverse events is not well studied.21
Despite what we know about multimodal analgesia, 
postoperative pain control, and the value of APS mod-
els, postoperative pain control is suboptimal around the 
world. In a questionnaire survey of 750 French surgical 
patients, 87% had postsurgical pain and 51% said it was 
severe to the worst pain imaginable.105 In the US, a phone 
survey (n=250) found 82% of surgical patients had pain 
for 2 weeks following surgery and 21% said it was severe.2 
The question arises: if we know what works, why does not 
the system work?
Postoperative pain control protocols exist and many are 
formally in place in hospitals and clinics, yet they may be 
unknown or incompletely known to clinicians and adherence 
is poor. With an increasingly strained and overburdened 
health care system, recovery room workloads may prevent 
careful adherence to protocols and, in some cases, there may 
not be a protocol in place for nurse-administered IV opioids. 
In some instances, clinical staff and hospital administration 
may not recognize the extreme importance of managing 
pain effectively. Poor protocol adherence and insufficient 
documentation may also occur.
It is the experience of the authors that change must be 
driven at an executive or administrative level of a facility. 
Once high-level advocates are found, clinicians can be mobi-
lized to optimize care. Clinical change is not something that 
is “done”; it is a continuous process.
Conclusion
Pain management has come a long way, but much more needs 
to be done to provide optimal analgesia for patients dealing 
with postoperative or other acute pain syndromes. Pain must 
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be assessed regularly, frequently, and with a validated instru-
ment. Clinicians must learn more about pain and share this 
knowledge with their patients. While many guidelines exist, 
clinicians need to understand and implement these guidelines 
better. Hospitals can benefit greatly from APS teams who, in 
turn, can help develop more recommendations, guidelines, 
education activities, and research endeavors, to assist us in 
gathering the evidence we need to reliably fight pain. Finally, 
we need to advocate strongly for the use of multimodal anal-
gesia as the standard of care for postoperative patients. When 
patients receive effective postoperative analgesia, it can reduce 
postoperative morbidity, enhance and accelerate recovery, 
shorten the hospital stay, and improve patient satisfaction.60 
Considering the relatively low cost of analgesic agents, this 
type of treatment has a very favorable cost-to-benefit ratio.
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